# The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension

> **NCT06015373** · NA · COMPLETED · sponsor: **Centro Hospitalar De São João, E.P.E.** · enrollment: 34 (actual)

## Conditions studied

- Clinically Significant Portal Hypertension

## Interventions

- **DRUG:** supress the night dose of carvedilol

## Key facts

- **NCT ID:** NCT06015373
- **Lead sponsor:** Centro Hospitalar De São João, E.P.E.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015373, "The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06015373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*